Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A Case of HIV-Associated Primary Central Nervous System Lymphoma Refractory to Methotrexate-Based Systemic Therapy and Immune Reconstitution.
Journal: Cureus
Published: February 24, 2025
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 10, 2024
CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma.
Journal: Blood advances
Published: June 04, 2024
CAR T-Cell Immunotherapy in Minority Patients with Lymphoma.
Journal: NEJM evidence
Published: May 22, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 29, 2024
Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 04, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 20, 2023
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas.
Journal: Transplantation and cellular therapy
Published: April 05, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 05, 2022
Last Updated: 09/26/2026